Movement Disorders Clinical Trials

Find Movement Disorders Clinical Trials Near You

Effects of Aerobic Training on Cerebrovascular Function, Cognitive Performance and Gait Parameters in Patients With Parkinson's Disease: A Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• Clinical diagnosis of Parkinson's disease

• Hoehn \& Yahr stages 1-3

• Stable antiparkinsonian medication for at least 4 weeks

• Montreal Cognitive Assessment (MoCA) score ≥ 18

• Ability to walk independently (with or without assistive device)

• Medical clearance for participation in moderate-intensity exercise

Locations
Other Locations
Brazil
Associação Brasil Parkinson
RECRUITING
São Paulo
Contact Information
Primary
Raphael M Ritti-Dias, PhD
raphaelritti@gmail.com
+5519999406878
Backup
Hélcio Kanegusuku, PhD
helciokng@gmail.com
+55 11 99539-9557
Time Frame
Start Date: 2026-02-28
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 40
Treatments
Experimental: Aerobic Training
Participants will perform supervised aerobic training on a cycle ergometer, 3 times per week for 12 weeks, 40 minutes per session, at perceived exertion 12-13 on Borg scale.
Other: Usual Care
Participants will maintain their usual clinical care and daily activities without structured exercise intervention.
Related Therapeutic Areas
Sponsors
Leads: Raphael Mendes Ritti Dias

This content was sourced from clinicaltrials.gov